首页> 外文OA文献 >The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus
【2h】

The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus

机译:针对巴西paracoccidioides主要诊断抗原的单克隆抗体介导受感染的BaLB / c小鼠的免疫保护,所述BaLB / c小鼠经真菌气管内攻击

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The protective role of specific antibodies against Paracoccidioides brasiliensis is controversial. In the present study, we analyzed the effects of monoclonal antibodies on the major diagnostic antigen (gp43) using in vitro and in vivo P. brasiliensis infection models. The passive administration of some monoclonal antibodies (MAbs) before and after intratracheal or intravenous infections led to a reduced fungal burden and decreased pulmonary inflammation. The protection mediated by MAb 3E, the most efficient MAb in the reduction of fungal burden, was associated with the enhanced phagocytosis of P. brasiliensis yeast cells by J774.16, MH-S, or primary macrophages. The ingestion of opsonized yeast cells led to an increase in NO production by macrophages. Passive immunization with MAb 3E induced enhanced levels of gamma interferon in the lungs of infected mice. The reactivity of MAb 3E against a panel of gp43-derived peptides suggested that the sequence NHVRIPIGWAV contains the binding epitope. The present work shows that some but not all MAbs against gp43 can reduce the fungal burden and identifies a new peptide candidate for vaccine development.
机译:特异性抗体对巴西副球菌的保护作用是有争议的。在本研究中,我们使用体外和体内的巴西假单胞菌感染模型分析了单克隆抗体对主要诊断抗原(gp43)的影响。在气管内或静脉内感染之前和之后被动施用某些单克隆抗体(MAb)可减少真菌负担并减少肺部炎症。由MAb 3E介导的保护作用是减轻真菌负担最有效的MAb,它与J774.16,MH-S或原代巨噬细胞增强了巴西假单胞菌酵母细胞的吞噬作用有关。摄入调理过的酵母细胞会导致巨噬细胞的NO产生增加。用MAb 3E被动免疫可在感染小鼠的肺中诱导提高的γ干扰素水平。 MAb 3E对一组gp43衍生肽的反应性表明,序列NHVRIPIGWAV包含结合表位。目前的工作表明,针对gp43的某些但不是全部MAb可以减轻真菌负担,并鉴定出用于疫苗开发的新肽候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号